morganhealth.comCrawled Oct 14, 2026
Copyright 2023 JPMorgan Chase & Co. All rights reserved.
Women face significant challenges in accessing affordable and high-quality health care
Offering benefits is crucial for small- and mid-sized businesses (SMBs) and their ability to grow and thrive.
The company invests in mid-stage companies aligned with its mission and focused on meeting the needs of patients and employers.
Thyme Care raises $125 million in a Series E round at a valuation above $2 billion, led by Morgan Health with Humana and CVS Health Ventures participating. The virtual cancer-navigation company offers services to more than 10.5 million people across all 50 states, manages over $7 billion in oncology spend, and reports profitability with positive free cash flow. Its new parent, Thyme Companies, plans businesses focused on cancer-drug affordability and clinical-trial access, with its first business expected to launch later this year.
Morgan Health, JPMorgan Chase’s healthcare division, invests $50 million in Vera Whole Health to expand clinic-based primary care. Vera Whole Health, a CD&R portfolio company, focuses on shifting employer-provided healthcare toward value-based models. The partnership marks Morgan Health’s inaugural investment in the sector.
JPMorgan Chase is launching a new business unit focused on improving cost and quality in employer-sponsored healthcare. The initiative follows the dissolution of its joint venture, Haven, with Amazon and Berkshire Hathaway. The move reflects the bank’s continued focus on healthcare solutions for corporate clients.
JPMorgan Chase launches **Morgan Health**, a new business unit targeting employer-sponsored health plans. The division aims to enhance care for approximately **285,000 individuals** enrolled through its health benefits programs. This follows an earlier failed collaboration with two other corporate partners.

Morgan Health: Enhancing healthcare quality, efficiency, and equity for employers and families.